Documentation Centre

 

 

  of 1503 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Changes in diagnosed diabetes, obesity, and physical inactivity prevalence in US counties, 2004-2012. PLoS One. 2017;12:e0173428 June 23, 2017 Changes in diagnosed diabetes, obesity, and physical inactivity prevalence in US counties, 2004-2012. PLoS One. 2017;12:e0173428 Geiss LS, Kirtland K, Lin J, Shrestha S, Thompson T, Albright A, Gregg EW Key Publications
Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial: A cross-sectional analysis. PLoS One. 2017;12:e0172253 June 23, 2017 Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial: A cross-sectional analysis. PLoS One. 2017;12:e0172253 Rosique-Esteban N, Díaz-López A, Martínez-González MA, Corella D, Goday A, Martínez JA, Romaguera D, Vioque J et al. Key Publications
Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: A science advisory from the American Heart Association. Circulation. 2017;135:e867-e884 June 21, 2017 Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: A science advisory from the American Heart Association. Circulation. 2017;135:e867-e884 Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello RB, Kris-Etherton PM et al. Key Publications
Could you explain what is the CANHEART Health Index? June 21, 2017 Could you explain what is the CANHEART Health Index? Gillian Booth, MD, MSc, FRCPC, Associate Professor, Department of Medicine, University of Toronto; Adjunct Scientist, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada Expert Opinions
Video 0:48 min.
(4 MB)
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389:1399-1409 June 16, 2017 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389:1399-1409 le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DC, Van Gaal L, Ortiz RV, Wilding JP, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group Key Publications
Treating prediabetes in the obese: are GLP-1 analogues the answer? Lancet. 2017;389:1371-137 June 16, 2017 Treating prediabetes in the obese: are GLP-1 analogues the answer? Lancet. 2017;389:1371-137 Farr OM, Mantzoros CS Key Publications
Chronic consumption of artificial sweetener in packets or tablets and type 2 diabetes risk: Evidence from the E3N-European Prospective Investigation into Cancer and Nutrition study. Ann Nutr Metab. 2017;70:51-58 June 15, 2017 Chronic consumption of artificial sweetener in packets or tablets and type 2 diabetes risk: Evidence from the E3N-European Prospective Investigation into Cancer and Nutrition study. Ann Nutr Metab. 2017;70:51-58 Fagherazzi G, Gusto G, Affret A, Mancini FR, Dow C, Balkau B, Clavel-Chapelon F, Bonnet F, Boutron-Ruault MC Key Publications
Impact of diabetes duration on 3-year clinical outcomes following coronary revascularization. Coron Artery Dis. 2017;28:151-158 June 12, 2017 Impact of diabetes duration on 3-year clinical outcomes following coronary revascularization. Coron Artery Dis. 2017;28:151-158 Gao HY, Zhang EL, Liu QR, Gu HQ, Zhang H, Zheng Z, Yang YJ, Gao RL, Wu YJ Key Publications
Impact of weight gain on the evolution and regression of prediabetes: a quantitative analysis. Eur J Clin Nutr. 2017;71:206-211 June 09, 2017 Impact of weight gain on the evolution and regression of prediabetes: a quantitative analysis. Eur J Clin Nutr. 2017;71:206-211 Nakasone Y, Miyakoshi T, Sato Y, Yamauchi K, Hashikura R, Takayama M, Hirabayashi K, Koike H, Aizawa T Key Publications
Fatty acid intake and its dietary sources in relation with markers of type 2 diabetes risk: The NEO study. Eur J Clin Nutr. 2017;71:245-251 June 09, 2017 Fatty acid intake and its dietary sources in relation with markers of type 2 diabetes risk: The NEO study. Eur J Clin Nutr. 2017;71:245-251 Wanders AJ, Alssema M, de Koning EJ, le Cessie S, de Vries JH, Zock PL, Rosendaal FR, Heijer MD, de Mutsert R Key Publications

  of 1503 Next page

Go to page: of